Opportunities for NanoTheranosis in Lung Cancer and Pulmonary Metastasis.

Journal article

Malignancies of the lungs, both primary and metastatic, are the leading cause of death worldwide. Over 1.5 million new cases of primary lung cancer are diagnosed annually worldwide with a dismal five-year survival rate of approximately 15%, which remains unchanged despite major efforts and medical advances. As expected, survival for patients with lung metastases is even worse at about 5%. Early detection and staging are fundamental in improving survival rates and selecting the most effective ...

Expand abstract

Authors: Key, J; Kim, Y; Tatulli, F; Palange, A; O'Neill, B

• Journal: Clinical and translational imaging
• Volume: 2
• Issue: 5
• Pages: 427-437
• Publication date: 2014-10-01
• DOI: 10.1007/s40336-014-0078-7
• EISSN: 2281-7565
• ISSN: 2281-5872
• Language: English